The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage

por Tuskey, Anne, Peura, David
Publicado 2013

Balancing the gastrointestinal benefits and risks of nonselective NSAIDs

por Peura, David A, Goldkind, Lawrence
Publicado 2005

Managing gastroesophageal reflux disease – comparative efficacy and outcomes of dexlansoprazole MR

por Frye, Jeanetta W, Peura, David A
Publicado 2015

Delayed release dexlansoprazole in the treatment of GERD and erosive esophagitis

por Wittbrodt, Eric T, Baum, Charles, Peura, David A
Publicado 2009

25 Years of Proton Pump Inhibitors: A Comprehensive Review

por Strand, Daniel S., Kim, Daejin, Peura, David A.
Publicado 2017

Analysis of the symptom response to esomeprazole 20 mg over days 1–4 of a 14-day course of treatment for frequent heartburn: results of two randomised controlled trials

por Peura, David, Le Moigne, Anne, Wassel, Heather, Pollack, Charles
Publicado 2019

Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials

por Peura, David A., Le Moigne, Anne, Wassel, Heather, Pollack, Charles
Publicado 2018

Long-Term Efficacy of Lansoprazole in Preventing Relapse of Erosive Reflux Esophagitis

por Kovacs, Thomas O., Freston, James W., Haber, Marian M., Hunt, Barbara, Atkinson, Stuart, Peura, David A.
Publicado 2009

Long-Term Quality of Life Improvement in Subjects with Healed Erosive Esophagitis: Treatment with Lansoprazole

por Kovacs, Thomas O., Freston, James W., Haber, Marian M., Atkinson, Stuart, Hunt, Barbara, Peura, David A.
Publicado 2009

Pharmacodynamic evaluation of intragastric pH and implications for famotidine dosing in the prophylaxis of non-steroidal anti-inflammatory drug induced gastropathy—a proof of conce...

por Kent, Jeffery D., Holt, Robert J., Jung, Donald, Tidmarsh, George F., Grahn, Amy Y., Ball, Julie, Peura, David A.
Publicado 2014